Personalized Serial Circulating Tumor DNA Analysis in High-Risk Early Stage Breast Cancer Patients
Analysis of circulating tumor DNA (ctDNA) offers a minimally invasive approach for monitoring treatment response and resistance to treatment in patients with breast cancer.